107 related articles for article (PubMed ID: 10706106)
21. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
[TBL] [Abstract][Full Text] [Related]
22. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway.
Watanabe Y; Kinoshita A; Yamada T; Ohta T; Kishino T; Matsumoto N; Ishikawa M; Niikawa N; Yoshiura K
J Hum Genet; 2002; 47(9):478-83. PubMed ID: 12202987
[TBL] [Abstract][Full Text] [Related]
23. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
24. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity.
Hummer BT; Bartlett C; Henry E; Weissman BE
J Cell Physiol; 2003 Mar; 194(3):289-302. PubMed ID: 12548549
[TBL] [Abstract][Full Text] [Related]
25. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
[TBL] [Abstract][Full Text] [Related]
26. Smad2 and Smad4 gene mutations in hepatocellular carcinoma.
Yakicier MC; Irmak MB; Romano A; Kew M; Ozturk M
Oncogene; 1999 Aug; 18(34):4879-83. PubMed ID: 10490821
[TBL] [Abstract][Full Text] [Related]
27. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
28. Mechanism for mutational inactivation of the tumor suppressor Smad2.
Prunier C; Ferrand N; Frottier B; Pessah M; Atfi A
Mol Cell Biol; 2001 May; 21(10):3302-13. PubMed ID: 11313456
[TBL] [Abstract][Full Text] [Related]
29. Mad-related genes in the human.
Riggins GJ; Thiagalingam S; Rozenblum E; Weinstein CL; Kern SE; Hamilton SR; Willson JK; Markowitz SD; Kinzler KW; Vogelstein B
Nat Genet; 1996 Jul; 13(3):347-9. PubMed ID: 8673135
[TBL] [Abstract][Full Text] [Related]
30. Dpc4 transcriptional activation and dysfunction in cancer cells.
Dai JL; Turnacioglu KK; Schutte M; Sugar AY; Kern SE
Cancer Res; 1998 Oct; 58(20):4592-7. PubMed ID: 9788608
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
32. Alterations of the transforming growth factor-beta signaling pathway in hepatocellular carcinomas induced endogenously and exogenously in rats.
Sasaki Y; Tsujiuchi T; Murata N; Tsutsumi M; Konishi Y
Jpn J Cancer Res; 2001 Jan; 92(1):16-22. PubMed ID: 11173539
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers.
Woodford-Richens KL; Rowan AJ; Poulsom R; Bevan S; Salovaara R; Aaltonen LA; Houlston RS; Wright NA; Tomlinson IP
Am J Pathol; 2001 Oct; 159(4):1293-300. PubMed ID: 11583957
[TBL] [Abstract][Full Text] [Related]
34. Aberrant signaling of TGF-beta1 by the mutant Smad4 in gastric cancer cells.
Ju HR; Jung U; Sonn CH; Yoon SR; Jeon JH; Yang Y; Lee KN; Choi I
Cancer Lett; 2003 Jul; 196(2):197-206. PubMed ID: 12860278
[TBL] [Abstract][Full Text] [Related]
35. Immunolocalization of Smad4 protein in the testis of domestic fowl (Gallus domesticus) during postnatal development.
Zhang XJ; Wen XX; Zhao L; He JP
Acta Histochem; 2012 Sep; 114(5):429-33. PubMed ID: 21890179
[TBL] [Abstract][Full Text] [Related]
36. Mutation analysis of transforming growth factor beta type II receptor, Smad2, Smad3 and Smad4 in esophageal squamous cell carcinoma.
Osawa H; Shitara Y; Shoji H; Mogi A; Kuwano H; Hagiwara K; Takenoshita S
Int J Oncol; 2000 Oct; 17(4):723-8. PubMed ID: 10995883
[TBL] [Abstract][Full Text] [Related]
37. Expression and localization of the transforming growth factor-beta type I receptor and Smads in preneoplastic lesions during chemical hepatocarcinogenesis in rats.
Park DY; Lee CH; Sol MY; Suh KS; Yoon SY; Kim JW
J Korean Med Sci; 2003 Aug; 18(4):510-9. PubMed ID: 12923327
[TBL] [Abstract][Full Text] [Related]
38. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4.
Hata A; Lo RS; Wotton D; Lagna G; Massagué J
Nature; 1997 Jul; 388(6637):82-7. PubMed ID: 9214507
[TBL] [Abstract][Full Text] [Related]
39. Expression and localization of Smad1, Smad2 and Smad4 proteins in rat testis during postnatal development.
Hu J; Zhang YQ; Liu XP; Wang RA; Jin Y; Xu RJ
Asian J Androl; 2003 Mar; 5(1):51-5. PubMed ID: 12647004
[TBL] [Abstract][Full Text] [Related]
40. Expression of SMAD proteins, TGF-beta/activin signaling mediators, in human thyroid tissues.
Matsuo SE; Fiore AP; Siguematu SM; Ebina KN; Friguglietti CU; Ferro MC; Kulcsar MA; Kimura ET
Arq Bras Endocrinol Metabol; 2010 Jun; 54(4):406-12. PubMed ID: 20625653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
